
Collaboration - December 6, 2013
Genmab announces expansion with Janssen Biotech
Genmab have announced an expansion of its collaboration with Janssen Biotech to create and develop bispecific antibodies using the DuoBody technology platform. The original agreement entitled Janssen to work on up to ten DuoBody programs. Under the terms of the amendment, Janssen is entitled to work on up to ten additional programs. Genmab will receive […]